Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Molecular targeting strategies are crucial for cancer progression control.
• Enzymes in metabolic pathways play key roles in cancer.
• Sphingolipid metabolism is significant in cancer treatments.

Purpose of the Study:

• To review enzymes involved in cancer-associated metabolic pathways.
• To discuss natural product-derived inhibitors of these enzymes.
• To highlight the therapeutic potential of targeting ceramide metabolism.

Main Methods:

• Literature review of enzymes in cancer metabolic pathways.
• Analysis of physicochemical properties of natural product inhibitors.
• Examination of preclinical data on ceramide metabolism targeting.

Main Results:

• Identified key enzymes: ceramidase, sphingosine kinase, sphingomyelin synthase, dihydroceramide desaturase, and ceramide synthase.
• Discussed natural product inhibitors and their structures.
• Preclinical studies show promise for mono- and combination therapies targeting ceramide metabolism.

Conclusions:

• Targeting ceramide metabolism is a promising strategy for cancer treatment.
• Sphingolipid metabolism is a significant area for cancer therapy development.
• Medicinal chemists can design potent small molecules for cancer progression by targeting ceramide-metabolizing enzymes.